Multiple sclerosis. Multiple sclerosis
Conditions
Interventions
Intervention 1: Intervention group: They will receive a dose of 1000 mg of omega-3 for three months, two omega-3 softgels daily. Intervention 2: Control group: will receive a dose of 1000 mg of omega-
Sponsors
Abadan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 85 Years
Inclusion criteria
Inclusion criteria: Patients with MS (diagnosis of MS based on McDonald's criteria) Age 18 to 85 years All types of MS (relapsing-remitting and progressive types) Treated with MS course-modifying drugs at a fixed dose for 6 months before study enrollment
Exclusion criteria
Exclusion criteria: Participants in other trials except the present clinical trial Recurrence or treatment with corticosteroids in the last month Simultaneous treatment with antibiotics and antihypertensive drugs Other acute or severe diseases except MS Pregnancy Current or past history of ventricular arrhythmia A general health condition that interferes with participation in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum interferon-gamma level. Timepoint: Interferon gamma serum levels will be measured before and after the period of use (3 months) in the drug and placebo groups. Method of measurement: Using a specialized kit for measuring interferon gamma by ELISA method. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum interferon- gamma level. Timepoint: Before the start of the intervention - day 1 of the study and after the end of the intervention - day 90 of the study. Method of measurement: Using a specialized kit for measuring interferon gamma factor in human serum by ELISA method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSahar Golabi
Abadan University of Medical Sciences
Outcome results
None listed